Breast Sarcomas, Phyllodes Tumors, and Desmoid Tumors: Turning the Magnifying Glass on Rare and Aggressive Entities
Authors:
- Miguel Esperança-MartinsMEMiguel Esperança-Martins
- Cecília Melo-AlvimCMCecília Melo-Alvim
- Sara DâmasoSDSara Dâmaso
- Raquel Lopes-BrásRLRaquel Lopes-Brás
- Tânia PenicheTPTânia Peniche
- Gonçalo Nogueira-CostaGNGonçalo Nogueira-Costa
- Catarina AbreuCACatarina Abreu
- Helena Luna PaisHPHelena Luna Pais
- Rita Teixeira de SousaRSRita Teixeira de Sousa
- Sofia TorresSTSofia Torres
- Lina Marcela Gallego-PaezLGLina Marcela Gallego-Paez
- Marta MartinsMMMarta Martins
Open Access
Abstract
Breast sarcomas (BSs), phyllodes tumors (PTs), and desmoid tumors (DTs) are rare entities that arise from connective tissue. BSs can be classified as either primary or secondary, whether they develop de novo or after radiation exposure or lymphedema. PIK3CA seems to play an important common role in different BS. Malignant PTs show similar behavior to BSs, while DTs are locally aggressive but rarely metastasize. BSs usually present as unilateral, painless, rapidly growing masses with rare nodal involvement. The diagnosis should be based on magnetic resonance imaging and a core needle biopsy. Staging should comprise a chest computed tomography (CT) scan (except for benign PT and DT), while abdominal and pelvic CT scans and bone scans should be added in certain subtypes. The mainstay of treatment for localized BS is surgery, with margin goals that vary according to subtype. Radiotherapy and chemotherapy can be used as neoadjuvant or adjuvant approaches, but their use in these settings is not standard. Advanced BS should be treated with systemic therapy, consistent with recommendations for advanced soft tissue sarcomas of other topographies. Given the rarity and heterogeneity of these entities, multidisciplinary and multi-institutional collaboration and treatment at reference centers are critical.Keywords
This publication has 111 references indexed in Scilit:
- Phyllodes Tumor of Breast: A Review ArticleISRN Surgery, 2013
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- Radiation-Associated Angiosarcoma After Breast Cancer: High Recurrence Rate and Poor Survival Despite Surgical Treatment with R0 ResectionAnnals of Surgical Oncology, 2012
- Phospholipase C-γ1 is required for the epidermal growth factor receptor-induced squamous cell carcinoma cell mitogenesisBiochemical and Biophysical Research Communications, 2010
- Phase II Study of Sorafenib in Patients With Metastatic or Recurrent SarcomasJournal of Clinical Oncology, 2009
- Phyllodes tumors of the breast segregate in two groups according to genetic criteriaLaboratory Investigation, 2007
- Knockdown of ALR (MLL2) Reveals ALR Target Genes and Leads to Alterations in Cell Adhesion and GrowthMolecular and Cellular Biology, 2007
- Primary sarcoma of the breastJournal of Surgical Oncology, 2004
- Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literatureBritish Journal of Cancer, 2004
- The importance of a multidisciplinary group in the treatment of soft tissue sarcomasEuropean Journal of Cancer, 1996